Germany · 
Who invested in CollimateHealth?
CollimateHealth's investors include HTGF High-Tech Gründerfonds, XISTA Science Ventures, Caesar., VP Venture Partners and Positron Ventures, and 1 more on record.
2026
?Round$6.9MSeedGermany · Seed startup
Who invested in CollimateHealth
Funding summaryUpdated 26 Oct 2026
$6.9Mraised across 2 rounds since 2025, from 4 sources
- Latest round
- Seed, $6.9MJun 2026
- Investors
- 6 (1 led)
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Round Jul 2025
- Biggest round
- $6.9M Seed · Jun 2026
- Between rounds
- 11 months from the last two
The rounds
- Jun 2026Seed$6.9M1 new4 returning
Reported by Firms' own news pages and 2 others
- Jul 2025RoundAmount undisclosed5 new
Reported by Firms' own news pages
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about CollimateHealth
How much has CollimateHealth raised?
CollimateHealth has raised $6.9M across 2 rounds since 2025. One round did not disclose an amount, so the total is a floor.
When did CollimateHealth last raise?
CollimateHealth's most recent round was a Seed of $6.9M in Jun 2026.
What was CollimateHealth's biggest round?
Its most recent round, $6.9M in Jun 2026, is also its largest on record.
Who backed CollimateHealth first?
CollimateHealth's first round on record, in Jul 2025, was backed by Positron Ventures, HTGF High-Tech Gründerfonds and XISTA Science Ventures and 2 others.
What stage is CollimateHealth at?
CollimateHealth's latest named round is a Seed, in Jun 2026.
Where is CollimateHealth based?
CollimateHealth is based in Germany.
Who led CollimateHealth's rounds?
Positron Ventures led the funding round in 2025.
Companies like CollimateHealth
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.